The landscape of dementia analysis has advanced substantially with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-centered checks that may detect Alzheimer's pathology a long time in advance of indications emerge. Whilst these technological developments depict amazing development in comprehending neurodegenera